Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatmentY Wang(The Barbara Ann Karmanos Cancer Institute), A. Raz(The Barbara Ann Karmanos Cancer Institute)Cell Death and DiseaseNovember 18, 201010.1038/cddis.2010.79Cited by 76SaveCiteExport RISWatch citationsRelated PapersThe significance of galectin-3 as a new basal cell marker in prostate cancer|Cell Death and Disease|2013|36